Showing results (91-100 of 147) with videos related to

Sort By:
Pageof 15
Antiviral Chemistry & Chemotherapy|September 20, 2002
Comparative study of bis(benzyl)phosphate triesters of 2',3'-dideoxy-2',3'-didehydrothymidine (d4T) and cyclosal-d4TMP--hydrolysis, mechanistic insights and anti-HIV activityChris Meier, Ulrike Muus, Jürgen Renze, et al.
Prenatal Diagnosis|February 8, 2003
Maternal serum marker medians in Aboriginal Canadian womenTianhua Huang, Anne M Summers, Philip R Wyatt, et al.
Cancer Discovery|April 18, 2026
Enabling AI to Drive Innovation and Precision across Oncology R&DRichard J A Goodwin, Simon T Barry, James Weatherall, et al.
Journal of Medicinal Chemistry|November 13, 2020
γ-Ketobenzyl-Modified Nucleoside Triphosphate Prodrugs as Potential AntiviralsTobias Nack, Thiago Dinis de Oliveira, Stefan Weber, et al.
Obstetrics and Gynecology|February 3, 2005
Greater maternal weight and the ongoing risk of neural tube defects after folic acid flour fortificationJoel G Ray, Philip R Wyatt, Marian J Vermeulen, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 18, 2004
Maternal ethnicity and risk of neural tube defects: a population-based studyJoel G Ray, Marian J Vermeulen, Chris Meier, et al.
The Journal of Pediatrics|December 6, 2003
Association between folic acid food fortification and congenital orofacial cleftsJoel G Ray, Chris Meier, Marian J Vermeulen, et al.
American Journal of Obstetrics and Gynecology|September 19, 2002
Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomesDavid Chitayat, Sandra A Farrell, Tianhua Huang, et al.
American Journal of Medical Genetics. Part A|July 3, 2003
Prevalence of trisomy 21 following folic acid food fortificationJoel G Ray, Chris Meier, Marian J Vermeulen, et al.
Biochemistry|March 5, 2003
Structures of human thymidylate kinase in complex with prodrugs: implications for the structure-based design of novel compoundsNils Ostermann, Dario Segura-Peña, Chris Meier, et al.
Pageof 15